Literature DB >> 10740840

[Functional role of V1- and V2-receptors of the apical and basolateral membranes of the frog bladder epithelial cells].

N P Prutskova1, E I Shakhmatova, Iu V Natochin.   

Abstract

Arginine vasotocin, 0.02--1 nM, increases osmotic water permeability of frog urinary bladder, arginine vasotocin after a simultaneous addition to the mucosal and serosal Ringer solutions rises the water permeability to a lesser degree than on the hormone addition only to the serosal solution. 1 nM remestyp, an agonist of V1-receptors, from the apical membrane decreases the hydroosmotic effect of arginine vasotocin added to the serosal Ringer solution. When added to the mucosal solution, combination of the same concentrations of arginine vasotocin and SR 49059, an antagonist of V--receptors, or desmopressin, agonist of V2-receptor alone, increases the effect of the same concentration of arginine vasotocin added to the serosal solution. 1 nM arginine vasotocin at the luminal membrane increases secretion into the Ringer solution of prostaglandin E, and prostaglandin E1 but not of prostaglandin F2 alpha. The data obtained indicate the presence of the arginine vasotocin receptors responsible for the hydroosmotic effect only in the basolateral membranes, while arginine prostaglandin E, participation is shown in modulation of the arginine vasotocin effect.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10740840

Source DB:  PubMed          Journal:  Ross Fiziol Zh Im I M Sechenova        ISSN: 0869-8139


  2 in total

1.  The role of prostaglandin E2 in the recovery of water impermeability of the frog urinary bladder epithelium after action of vasotocin.

Authors:  Y Natochin; N P Prutskova; E I Shakhmatova
Journal:  Dokl Biol Sci       Date:  2001 Jul-Aug

2.  Expression of type II hyaluronan-synthase gene in kidneys Wistar and Brattleboro rats with diabetes insipidus: effect of vasopressin and its analogues.

Authors:  N O Kabilova; A A Bondar; L N Ivanova
Journal:  Dokl Biochem Biophys       Date:  2009 Mar-Apr       Impact factor: 0.788

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.